Changes

54 bytes added ,  09:50, 28 July 2016
Line 82: Line 82:  
== Prognosis ==
 
== Prognosis ==
   −
Write your comments here
+
Type II is more aggressive and may progress to malignant eosinophillic chrRCC.
    
== Therapeutics ==
 
== Therapeutics ==